세계의 수술 시뮬레이션 시장 : 예측(2025-2030년)

The surgical simulation market is expected to grow from USD 402.280 million in 2025 to USD 852.234 million in 2030, at a CAGR of 16.20%.

Surgical simulation represents a computer technology developed to train medical practitioners without requiring patients or animals for training purposes. The technology utilizes motion sensors and three-dimensional graphics to create realistic surgical experiences, enabling users to perform complete surgeries on virtual organs while physically sensing tissue and organ characteristics. This immersive training environment helps minimize medical errors and infection rates by allowing trainees to learn from mistakes without risking patient lives.

Market Drivers

Rising Chronic Disease Prevalence

The increasing number of chronic disease cases worldwide represents a major driver for surgical simulation market growth. According to the World Health Organization, chronic diseases (non-communicable diseases) account for 71% of global deaths, equivalent to 41 million annual deaths. Asian countries are experiencing chronic diseases as a growing health concern, with the World Economic Forum noting that one in three adults worldwide has multiple chronic conditions including cardiovascular disease, diabetes, depression, cancer, or combinations of multiple diseases simultaneously.

Non-communicable diseases represent more than half the global disease burden. This surge in chronic diseases has led the global healthcare system to recognize the critical importance of surgical simulation technology for training qualified medical professionals capable of addressing complex medical conditions requiring surgical intervention.

Demographic Transition and Aging Population

The world approaches a significant demographic milestone with rapidly aging populations globally, necessitating both technology-driven healthcare systems and cutting-edge medical training. The World Health Organization projects the population aged 65 or older will grow from an estimated 524 million in 2010 to nearly 1.5 billion by 2050, with most increases occurring in developing countries.

This continuously aging population challenges healthcare systems worldwide. The dramatic rise in elderly populations is most prominent in Asia followed by Europe, according to Population Reference Bureau data showing Japan with 28% of population aged 65 and above, followed by Italy, Finland, and Greece. China has 12% of population and the United States has 16% of population aged 65 and above.

The continuous population aging creates demand for technology-driven surgical simulation to train more surgeons globally, ensuring healthcare demand is effectively met through qualified medical professionals.

Developing Country Awareness and Adoption

Developing countries present significant opportunities for surgical simulation market expansion as awareness about training techniques rapidly increases. Development programs organized in developing economies spread awareness about surgical simulation training benefits.

The World Health Organization reports annual cardiovascular disease mortality at 17.9 million deaths, while cancer claims 9.6 million lives annually. Most chronic disease sufferers reside in developing countries, with WHO estimates showing 85% of these deaths occurring in low- and middle-income countries. Rapid unplanned urbanization and globalization of unhealthy lifestyles contribute prominently to these statistics.

Developing countries must adopt technology-driven healthcare facilities, transition toward conventional medical systems, and train more surgeons to meet growing demand for improved healthcare systems.

Competitive Investment and Market Development

Rising competition and investment boost surgical simulation market growth through strategic development initiatives. Prominent market players include CAE Inc., Simulab Corporation, and 3D Systems, Inc. MEDICAL-X, implementing various development strategies to achieve competitive market advantages.

North America is forecasted to account for considerable surgical simulation market share. The Asia-Pacific market demonstrates projected growth due to high technological developments and aging population demographics. Academic and research institutes are expanding rapidly due to government funding, leading to increased surgical training adoption and enhanced surgeon proficiency.

Geographic Market Analysis

Regional market distribution shows North America maintaining significant market presence while Asia-Pacific regions demonstrate strong growth potential. Government funding support for academic and research institutions creates favorable conditions for surgical simulation technology adoption across educational and healthcare facilities.

Market Outlook

The surgical simulation market benefits from fundamental healthcare trends including chronic disease prevalence, demographic aging, and technological advancement in medical education. The combination of healthcare system pressures, training requirements, and technological capabilities positions surgical simulation as an essential component of modern medical education and professional development across global healthcare markets.

This technology addresses critical healthcare challenges while providing safe, cost-effective training solutions that improve surgical outcomes through enhanced practitioner skills and reduced medical errors.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Surgical Simulation Market Segments:

By Product

• Laparoscopic
• Neurological
• Gynecological
• Cardiovascular
• Arthroscopic
• Endoscopic
• Others

By End-User

• Hospitals
• Research and Academic Institutes
• Surgical Clinics
• Military Organizations

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SURGICAL SIMULATION MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Laparoscopic
• 5.3. Neurological
• 5.4. Gynecological
• 5.5. Cardiovascular
• 5.6. Arthroscopic
• 5.7. Endoscopic
• 5.8. Others

6. SURGICAL SIMULATION MARKET BY END-USER

• 6.1. Introduction
• 6.2. Hospitals
• 6.3. Research and Academic Institutes
• 6.4. Surgical Clinics
• 6.5. Military Organizations

7. SURGICAL SIMULATION MARKET BY GEOGRAPHY

• 7.1. Introduction
• 7.2. North America
  • 7.2.1. USA
  • 7.2.2. Canada
  • 7.2.3. Mexico
• 7.3. South America
  • 7.3.1. Brazil
  • 7.3.2. Argentina
  • 7.3.3. Others
• 7.4. Europe
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. United Kingdom
  • 7.4.4. Spain
  • 7.4.5. Others
• 7.5. Middle East and Africa
  • 7.5.1. Saudi Arabia
  • 7.5.2. UAE
  • 7.5.3. Others
• 7.6. Asia Pacific
  • 7.6.1. China
  • 7.6.2. India
  • 7.6.3. Japan
  • 7.6.4. South Korea
  • 7.6.5. Indonesia
  • 7.6.6. Thailand
  • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 8.1. Major Players and Strategy Analysis
• 8.2. Market Share Analysis
• 8.3. Mergers, Acquisitions, Agreements, and Collaborations
• 8.4. Competitive Dashboard

9. COMPANY PROFILES

• 9.1. CAE Inc.
• 9.2. Gaumard Scientific Company, Inc
• 9.3. Simulab Corporation
• 9.4. Surgical Science Sweden AB
• 9.5. 3B Scientific
• 9.6. Simendo B.V.
• 9.7. 3D Systems, Inc
• 9.8. VirtaMed AG
• 9.9. MEDICAL-X
• 9.10. OSSim Tech

10. APPENDIX

• 10.1. Currency
• 10.2. Assumptions
• 10.3. Base and Forecast Years Timeline
• 10.4. Key benefits for the stakeholders
• 10.5. Research Methodology
• 10.6. Abbreviations